Market Tracker

04/17 6:05pm ET

Immunomedics Inc (NASDAQ:IMMU)

3.96
Data as of Apr 17
 -0.03 / -0.75%
Today’s Change
2.40
Today|||52-Week Range
7.35
-13.91%
Year-to-Date

Today’s Trading

Previous close3.99
Today’s open3.97
Day’s range3.86 - 4.08
Volume387,384
Average volume (3 months)850,713
Market cap$332.4M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-1,700.00%
Earnings growth (this year)-43.75%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-84.84%
P/E ratioNM
Price/Sales85.56
Price/Book8.94

Competitors

 Today’s
change
Today’s
% change
LMNSLumenis Ltd+0.74+8.39%
CLDNCelladon Corp+0.44+3.83%
TEARTearLab Corp-0.35-7.03%
CUTRCutera Inc-0.22-2.00%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 12, 2014
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$5.0M
Annual profit (last year)-$12.2M
Net profit margin-245.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Medical Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts